Researchers Exploring CAR T-Cell Therapy in NSCLC – Targeted Oncology
Targeted Oncology |
Researchers Exploring CAR T-Cell Therapy in NSCLC
Targeted Oncology In hematologic malignancies, we have been using CAR T cells and try to pick out a molecule that we can then educate our patients' own T cells. Then, we can retransfuse them into patients and have them respond. We are doing similar approaches in lung … |
